整合生物信息学和代谢学,以确定高血压性病的潜在生物标志物
Kezhen Yang1, Pingna Zhang2, Xiaofeng Ding3
1Department of Rehabilitation Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qingchun Road, Hangzhou, 310016, Zhejiang, China. 767299632@qq.com.
Scientific reports
|March 3, 2025
概括
高血压性脏病 (HN) 涉及不清楚的途径. 这项研究确定了关键基因 (APOE,ALB,SERPINA1) 和胆酸 (CA,DCA,TDCA),与早期HN进展和高血压有关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 基因组学就是基因组学.
背景情况:
- 高血压脏病 (HN) 是末期脏疾病的主要原因,但其致病性仍然不清楚.
- 了解涉及HN进展的生物学途径和生物标志物对于早期诊断和治疗至关重要.
研究的目的:
- 确定涉及高血压脏病 (HN) 进展的生物途径.
- 为了发现HN的胆汁酸 (BA) 相关生物标志物.
- 阐明胆酸在HN发展中的作用.
主要方法:
- 下载并分析基因微阵列数据,以识别HN中差异表达基因 (DEGs).
- 在DEGs上进行了基因本体学和基因和基因组丰富分析的京都百科全书.
- 构建了一个蛋白质-蛋白质相互作用 (PPI) 网络,并集成BA目标以识别枢纽基因.
- 建立了早期高血压脏病动物模型 (SHR) 并量化了皮层中的39种胆酸.
主要成果:
- 确定了398个DEG和与高血压和病相关的多个生物学途径.
- 发现了三个BA相关的枢纽基因:APOE,ALB和SERPINA1.
- 在早期HN中发现了七种胆酸 (DCA,CDCA,UDCA,UCA,CA,TDCA,TCDCA) 的显著度差异.
- 在SHR模型中观察到特定胆汁酸 (CA,DCA,TDCA) 和血压之间的正相关性,表明诊断潜力.
结论:
- 已确定的枢纽基因 (APOE,ALB,SERPINA1) 和高胆酸,特别是CA,DCA和TDCA,可能与高血压脏病 (HN) 的早期阶段有关.
- 这些与BA相关的生物标志物与血压具有显著的相关性和特异性,这表明早期HN检测的诊断价值很高.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K


